CAMCEVI DIN 02567148
Status: Approved
Holder: ACCORD HEALTHCARE INC
Health Canada record
| Active ingredient(s) | LEUPROLIDE (LEUPROLIDE MESYLATE) 21 MG |
|---|
| Dosage form | Emulsion (Extended-Release) |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L02AE02 LEUPRORELIN |
|---|
| Original market date | |
|---|
| Current status date | 31-Mar-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Accord Healthcare Inc. — licence 101566, currently licensed, last inspection rating C (2024-11-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEUPROLIDE (LEUPROLIDE MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02522446 | CAMCEVI | ACCORD HEALTHCARE INC | Emulsion (Extended-Release) | LEUPROLIDE (LEUPROLIDE MESYLATE) 42 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37236 | 2026-03-31 | New Drug Submission (NDS) | |
Request a quote for CAMCEVI
How to read a Canadian DIN record